American Century Companies’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-47,929
Closed -$1.84M – 3002
2026
Q1
$1.84M Buy
47,929
+1,702
+4% +$55.1K ﹤0.01% 2148
2025
Q4
$1.22M Buy
46,227
+7,815
+20% +$144K ﹤0.01% 2256
2025
Q3
$537K Buy
38,412
+9,558
+33% +$109K ﹤0.01% 2491
2025
Q2
$276K Buy
28,854
+5,423
+23% +$51.5K ﹤0.01% 2686
2025
Q1
$218K Buy
23,431
+1,289
+6% +$16.7K ﹤0.01% 2746
2024
Q4
$308K Sell
22,142
-20,857
-49% -$379K ﹤0.01% 2678
2024
Q3
$1.01M Sell
42,999
-127,284
-75% -$2.67M ﹤0.01% 2229
2024
Q2
$2.72M Buy
170,283
+145,346
+583% +$2.5M ﹤0.01% 1772
2024
Q1
$409K Buy
24,937
+14,057
+129% +$231K ﹤0.01% 2523
2023
Q4
$151K Buy
+10,880
New +$141K ﹤0.01% 2752

Other funds holding TYRA

American Century Companies's TYRA Position: Q2 2026 in Review

American Century Companies sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 47,929 shares — an estimated $1.84M sold.

American Century Companies first reported a position in TYRA in Q4 2023 and held it in 10 quarters. The position peaked at $2.72M in Q2 2024. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • American Century Companies reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 47,929 Tyra Biosciences shares in Q2 2026, an estimated $1.84M.
  • American Century Companies first reported a position in Tyra Biosciences in Q4 2023 and held it in 10 quarters.
  • American Century Companies's Tyra Biosciences position peaked at $2.72M in Q2 2024.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.